Showing results (201-210 of 445) with videos related to
Sort By:
Pageof 45
Plos Medicine|November 5, 2004
Distribution of major health risks: findings from the Global Burden of Disease studyAnthony Rodgers, Majid Ezzati, Stephen Vander Hoorn, et al.European Journal of Preventive Cardiology|January 9, 2016
Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular diseaseMelvin Lafeber, Ruth Webster, Frank Lj Visseren, et al.BMJ Evidence-Based Medicine|June 5, 2021
Quality of systematic reviews supporting the 2017 ACC/AHA and 2018 ESC/ESH guidelines for the management of hypertensionRaju Kanukula, Rupasvi Dhurjati, Kota Vidyasagar, et al.Heart (British Cardiac Society)|August 8, 2022
Long working hours, sedentary work, noise, night shifts and risk of ischaemic heart diseaseAmanda Eng, Hayley J Denison, Marine Corbin, et al.The New Zealand Medical Journal|September 30, 2020
Inequity in one-year mortality after first myocardial infarction in Māori and Pacific patients: how much is associated with differences in modifiable clinical risk factors? (ANZACS-QI 49)Janine Mazengarb, Corina Grey, Mildred Lee, et al.Age and Ageing|January 25, 2022
Cardiovascular disease preventive medication dispensing for almost every New Zealander 65 years and over: a preventive treatment paradox?Sue Wells, Yeunhyang Choi, Rod Jackson, et al.European Journal of Preventive Cardiology|February 13, 2021
Cardiovascular preventive pharmacotherapy stratified by predicted cardiovascular risk: a national data linkage studySuneela Mehta, Jinfeng Zhao, Katrina Poppe, et al.Annals of Internal Medicine|February 26, 2019
Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Cohort StudyVanessa Selak, Rod Jackson, Katrina Poppe, et al.European Journal of Dermatology : EJD|April 16, 2003
Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair lossDavid A Whiting, Elise A Olsen, Ronald Savin, et al.American Heart Journal|June 8, 2019
Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United StatesThomas A Gaziano, Ankur Pandya, Stephen Sy, et al.Pageof 45